chr11-67645856-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_080658.2(ACY3):​c.268G>A​(p.Val90Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

ACY3
NM_080658.2 missense

Scores

1
7
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.581
Variant links:
Genes affected
ACY3 (HGNC:24104): (aminoacylase 3) Predicted to enable aminoacylase activity. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ACY3NM_080658.2 linkuse as main transcriptc.268G>A p.Val90Met missense_variant 4/8 ENST00000255082.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ACY3ENST00000255082.8 linkuse as main transcriptc.268G>A p.Val90Met missense_variant 4/81 NM_080658.2 P1
ACY3ENST00000529256.1 linkuse as main transcriptc.-96G>A 5_prime_UTR_variant 3/73

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 29, 2022The c.268G>A (p.V90M) alteration is located in exon 4 (coding exon 2) of the ACY3 gene. This alteration results from a G to A substitution at nucleotide position 268, causing the valine (V) at amino acid position 90 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Uncertain
0.037
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
18
DANN
Uncertain
1.0
DEOGEN2
Benign
0.41
T
Eigen
Benign
0.086
Eigen_PC
Benign
-0.041
FATHMM_MKL
Benign
0.39
N
LIST_S2
Benign
0.74
T
M_CAP
Uncertain
0.13
D
MetaRNN
Uncertain
0.73
D
MetaSVM
Pathogenic
0.85
D
MutationAssessor
Uncertain
2.2
M
MutationTaster
Benign
1.0
D;N
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-1.5
N
REVEL
Uncertain
0.45
Sift
Benign
0.037
D
Sift4G
Benign
0.067
T
Polyphen
1.0
D
Vest4
0.49
MutPred
0.60
Gain of catalytic residue at V90 (P = 0.0457);
MVP
0.85
MPC
0.25
ClinPred
0.80
D
GERP RS
3.0
Varity_R
0.099
gMVP
0.28

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr11-67413327; API